Phibro Animal Health (PAHC) Reports In-Line Q3 EPS, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results
May 6, 2021 4:40 PM EDTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced financial results for its third quarter and year-to-date period ended March 31, 2021.
Highlights for the March 31, 2021 quarter (compared to the quarter ended March 31, 2020)
Net sales of $212 million, an increase of $1 million, or less than 1% Net income of $12 million, a decrease of $1 million, or 10% Diluted EPS of $0.30, a decrease of $0.03, or 9% Adjusted EBITDA of $28 million, a decrease of $2 million, or 7% Adjusted Net Income of $14 million, a decrease of $2 million, or... More